ARGENT BIOPHARMA LIMITED (RGT)

---

AI Coverage Rating: High

ASX AI Signals has generated 8 signals for RGT during the last 90 days, indicating strong trading activity and ongoing AI monitoring

Latest RGT Signals
12/06/2026	SELL
11/06/2026	SELL
10/06/2026	SELL
RGT Share Price
Current Price	$0.037
52 Week High	$0.150
52 Week Low:	$0.033
Trading at (% of 52 Week High)	24.67%

Business Overview

Argent Biopharma Limited (ASX: RGT) is a biopharmaceutical company focused on developing and commercializing medical treatments. The company specializes in innovative therapies aimed at addressing unmet medical needs. Its activities include research, development, and potential commercialization of new drugs.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for ARGENT BIOPHARMA LIMITED (RGT) is supported by weak price momentum and potential liquidity concerns at the current low price level. However, limited publicly available fundamental data introduces some uncertainty, moderating the confidence level.

Latest  ARGENT BIOPHARMA LIMITED(RGT)   News